• Species Reactivity

  Mouse

• Specificity

  Detects mouse ST2/IL-33 R in ELISAs.

• Source

  Monoclonal Rat IgG    _2B Clone # 245707

• Purification

  Protein A or G purified from hybridoma culture supernatant

• Immunogen

  S. frugiperda insect ovarian cell line Sf 21-derived recombinant mouse ST2/IL-33 R    
  Ser27-Arg332    
  Accession # P14719

• Formulation

  Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 µm filtered solution in PBS.

• Label

  Unconjugated

Applications

• 
  

  Recommended    
  Concentration

  Sample

• Flow Cytometry

  0.25 µg/10    ⁶ cells

  See below

• 
  

• CyTOF-ready

  Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.

• 
  

• Mouse ST2/IL-33 R Sandwich Immunoassay

  Reagent    

• ELISA Capture (Matched Antibody Pair)

  2-8 µg/mL 

  Mouse ST2/IL-33 R Antibody (Catalog # )

• ELISA Detection (Matched Antibody Pair)

  0.1-0.4 µg/mL 

  Mouse ST2/IL-33 R Biotinylated Antibody (Catalog # )

• ELISA Standard

   

  Recombinant Mouse ST2/IL-33 R Fc Chimera Protein, CF (Catalog # )

• 
  

• Neutralization

  Measured by its ability to neutralize IL‑33-induced proliferation in the D10.G4.1 mouse helper T cell line. Schmitz, J. et al. (2005) Immunity 23:479. The Neutralization Dose (ND     ₅₀) is typically 0.5-3 ug/mL in the presence of 1 ng/mL Recombinant Human IL‑33.

Please Note: Optimal dilutions should be determined by each laboratory for each application.  are available in the Technical Information section on our website.

Data Examples

Preparation and Storage

• Reconstitution

  Reconstitute at 0.5 mg/mL in sterile PBS.

• Shipping

  The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. *Small pack size (SP) is shipped with polar packs. Upon receipt, store it immediately at -20 to -70 °C

• Stability & Storage

  Use a manual defrost freezer and avoid repeated freeze-thaw cycles.    

• 12 months from date of receipt, -20 to -70 °C as supplied.

• 1 month, 2 to 8 °C under sterile conditions after reconstitution.

• 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: ST2/IL-33 R

ST2, also known as IL-1 R4 and T1, is an Interleukin-1 receptor family glycoprotein that contributes to Th2 immune responses (1, 2). Mouse ST2 consists of a 306 amino acid (aa) extracellular domain (ECD) with three Ig-like domains, a 23 aa transmembrane segment, and a 212 aa cytoplasmic domain with an intracellular TIR domain (3). Alternate splicing of the 120 kDa mouse ST2 generates a soluble 60 kDa isoform that lacks the transmembrane and cytoplasmic regions (3). Within the ECD, mouse ST2 shares 68% and 81% aa sequence identity with human and rat ST2, respectively. ST2 is expressed on the surface of mast cells, activated Th2 cells, macrophages, and cardiac myocytes (4‑7). It binds IL-33, a cytokine that is up‑regulated by inflammation or mechanical strain in smooth muscle cells, airway epithelia, keratinocytes, and cardiac fibroblasts (4, 8). IL-33 binding induces the association of ST2 with IL-1R AcP, a shared signaling subunit that also associates with IL-1 RI and IL-1 R rp2 (1, 9, 10). In macrophages, ST2 interferes with signaling from IL-1 RI and TLR4 by sequestering the adaptor proteins MyD88 and Mal (6). In addition to its role in promoting mast cell and Th2 dependent inflammation, ST2 activation enhances antigen induced hypernociception and protects from atherosclerosis and cardiac hypertrophy (4, 11‑13). The soluble ST2 isoform is released by activated Th2 cells and strained cardiac myocytes and is elevated in the serum in allergic asthma (5, 7, 14). Soluble ST2 functions as a decoy receptor that blocks IL-33’s ability to signal through transmembrane ST2 (9, 12‑14).

• References:

1. Barksby, H.E. et al. (2007) Clin. Exp. Immunol. 149:217.

2. Gadina, M. and C.A. Jefferies (2007) Science STKE 2007:pe31.

3. Yanagisawa, K. et al. (1993) FEBS Lett. 318:83.

4. Schmitz, J. et al. (2005) Immunity 23:479.

5. Lecart, S. et al. (2002) Eur. J. Immunol. 32:2979.

6. Brint, E.K. et al. (2004) Nat. Immunol. 5:373.

7. Weinberg, E.O. et al. (2002) Circulation 106:2961.

8. Sanada S. et al. (2007) J. Clin. Invest. 117:1538

9. Palmer, G. et al. (2008) Cytokine 42:358.

10. Chackerian, A.A. et al. (2007) J. Immunol. 179:2551.

11. Allakhverdi, Z. et al. (2007) J. Immunol. 179:2051.

12. Verri Jr., W.A. et al. (2008) Proc. Natl. Acad. Sci. 105:2723.

13. Miller, A.M. et al. (2008) J. Exp. Med. 205:339.

14. Hayakawa, H. et al. (2007) J. Biol. Chem. 282:26369.

• Long Name:

  Interleukin 33 Receptor

• Entrez Gene IDs:

  9173 (Human); 17082 (Mouse)

• Alternate Names:

  DER4; Fit-1; IL-1 R4; IL1R4; IL-1R4; IL-1RL1; IL-33R; Ly84; ST2; ST2L; ST2V; suppression of tumorigenicity 2; T1